Rooted in the work of renowned French scientist Professor Jack Masquelier, a pioneer in the research and development of oligomeric proanthocyanidins (OPCs), MASQUELIER'S® is distinguished by its proprietary fingerprinted format’s extraction expertise, and decades of scientific research into the antioxidant properties of OPCs, supported by clinical studies.
Ron Sim, Founder and Executive Chairman, V3 Group, said, “Health is becoming one of the defining priorities for consumers globally. People are living longer, but the opportunity is to help them live better. The acquisition of MASQUELIER’S® brings decades of European nutritional science into LAC, strengthening the scientific foundation of our portfolio. Singapore remains our home market, and we are grateful for the trust our customers have placed in us over the years. We remain committed to serving them through our extensive retail presence across Singapore’s malls, even as we take LAC into new markets and pursue our ambition to build a health and wellness brand born in Asia for consumers globally.”
MASQUELIER’S® is also the originator and trademark holder of MASQUELIER’S® Anthogenol, one of the most widely recognised OPC supplement brands across Asia Pacific. LAC’s acquisition extends beyond a single product line to bring the foundational intellectual property and scientific heritage behind an established category into its portfolio. To date, MASQUELIER’S® French Pine Bark Extract has sold over 250 million tablets, making it one of LAC’s most significant and enduring product platforms across its Asian markets.
Accelerating LAC Global’s Regional Expansion
This expansion reflects LAC’s ambition to become Asia’s defining homegrown health and wellness brand. Through its directly owned retail and e-commerce network, supported by continued product innovation, LAC is making science-backed nutrition and supplementation more accessible to consumers across the region. As ageing populations, rising health consciousness and growing wellness expenditure reshape consumer priorities, LAC is well positioned to meet increasing demand for preventive health and everyday wellness solutions.
Looking ahead, LAC will deepen its presence in existing markets while pursuing new growth opportunities across Asia Pacific and internationally. Alongside its geographic expansion, LAC will continue to invest in product innovation and science-backed nutritional solutions, with a focus on preventive health, healthy ageing and the evolving wellness needs of consumers.
As LAC’s parent company, V3 Group will continue to support its growth through strategic capital, operational capabilities and regional connectivity. Across its broader portfolio, V3 Group remains focused on businesses with strong fundamentals and long-term growth potential, to build category-leading brand

No comments:
Post a Comment